Search

Salim L Merali

from Philadelphia, PA
Age ~62
Get Report
Also known as:
Salim A Merali, Salim R
Phone and address:
15110 Dahlia Dr, Philadelphia, PA 19116
(718) 956-5388
Related to:
Mehdi MeraliMichael Merali, 34Carmen L Merali, 66Jasmine C Merali, 29Gabriela ChavesJorge E Cardenas, 62Manuel F Chaves, 97Maria Elena Chaves, 58
Connected to:
Fatema Merali, 37Laila A Merali, 55Sukaina J Merali, 53Dave Meralus, 39Jason H Meram, 40Marie C Meram, 36Raad J Meram, 65Carlos J Meran, 62Jesus A Meran, 64Bill T Merana, 74

Salim Merali Phones & Addresses

  • 15110 Dahlia Dr, Philadelphia, PA 19116 (718) 956-5388
  • Phila, PA
  • Boca Raton, FL
  • 2415 21St St, Astoria, NY 11102 (718) 956-5388
  • 469 Rolling Rd, Bryn Mawr, PA 19010 (610) 526-9266
  • Palm Beach, FL

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: Associate degree or higher

Resumes

Resumes

Salim Merali Photo 1

Associate Dean Of Research

View page
Work:
Temple University
Professor of Pharmaceutical Sciences and Director of Proteomics
Temple University Nov 2013 - Jun 2015
Associate Professor of Pharmaceutical Sciences and Director of Proteomics
Temple University School of Medicine Nov 2013 - Jun 2015
Associate Dean of Research
Education:
Nyu School of Medicine 1993 - 1996
Doctorates Ccny School of Education 1988 - 1992
Doctorates, Doctor of Philosophy, Biochemistry
Skills:
Cancer
Biochemistry
Cell Culture
Cell Biology
Flow Cytometry
Cell Signaling
Confocal Microscopy
Proteomics
Fluorescence Microscopy
Medical Research
Immunofluorescence
Immunohistochemistry
Hplc
Dna
Pharmacology
Western Blotting
Science
Molecular Biology
Lifesciences
Languages:
Spanish
Swahili
Salim Merali Photo 2

Salim Merali

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Salim E. Merali
President
NEPTUNE HOTELS, LTD

Publications

Us Patents

Facile Diagnosis And Monitoring Of Pneumocystis Carinii Infection

View page
US Patent:
20050032035, Feb 10, 2005
Filed:
May 20, 2002
Appl. No.:
10/477980
Inventors:
Salim Merali - Queens NY, US
International Classification:
C12Q001/70
C12Q001/04
US Classification:
435005000, 435034000
Abstract:
Significantly low circulating, S-adenosylmethionine levels were found to be diagnostic for human infection, and rise in levels towards normal correlated with successful treatment. Diagnosis of injection and monitoring of progress of treatment based thereon are described.

Biomarkers Of Chronic Obstructive Pulmonary Disease

View page
US Patent:
20140030735, Jan 30, 2014
Filed:
Mar 7, 2012
Appl. No.:
14/003120
Inventors:
Salim Merali - Bryn Mawr PA, US
Steven G. Kelsen - Rydal PA, US
Carlos A. Barrero - Philadelphia PA, US
Assignee:
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
G01N 33/68
US Classification:
435 721, 435 23
Abstract:
The methods described herein are based on the discovery that the plasma level of a panel of specific proteins differs between two subject populations: 1) subjects at risk for chronic obstructive pulmonary disease (“COPD”) but not manifesting clinical symptoms of COPD; and 2) subjects having very severe COPD. The difference in plasma levels is statistically significant for each protein. The identification of these proteins thus facilitates susceptibility detection, early disease detection, disease severity assessment, disease progression monitoring, and therapy efficacy monitoring.

Nuclear Factor-Erythroid 2 Related Factor 2 (Nrf2) Biosensors And Modulators Of Nrf2

View page
US Patent:
20160146785, May 26, 2016
Filed:
Oct 9, 2013
Appl. No.:
14/435000
Inventors:
- Philadelphia PA, US
Salim MERALI - Bryn Mawr PA, US
Carlos A. BARRERO - Philadelphia PA, US
Assignee:
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
G01N 33/50
A61K 31/05
C07K 14/47
A61K 31/225
C12Q 1/68
A61K 31/353
A61K 31/136
Abstract:
Compositions include nucleic acid sequences encoding the C-terminal fragment of fragment (Seg3) of Nuclear factor-erythroid 2 related factor 2 (Nrf2). These compositions provide a target for identification of novel therapeutics having the ability to modulate the translation of Nrf2. Methods of treating subjects are also provided.

Method For Determining Disease Severity In Tauopathy-Related Neurodegenerative Disorders

View page
US Patent:
20150147766, May 28, 2015
Filed:
May 23, 2013
Appl. No.:
14/403876
Inventors:
- PHILADELPHIA PA, US
Salim Merali - Bryn Mawr PA, US
International Classification:
G01N 33/68
C12Q 1/37
US Classification:
435 792, 436501, 435 24, 435 71
Abstract:
A method for determining disease severity in a subject afflicted with a tauopathy-related neurodegenerative disease comprises detecting the level of a PINCH protein or isoform thereof in a test sample comprising brain tissue or cerebrospinal fluid. The PINCH protein level in the test sample indicates the relative severity of the tauopathy-related neurodegenerative disease afflicting the subject.

Diagnosis And Treatment Of Copd

View page
US Patent:
20140294843, Oct 2, 2014
Filed:
May 11, 2012
Appl. No.:
14/117157
Inventors:
Salim Merali - Bryn Mawr PA, US
Camilo Moncada - Philadelphia PA, US
Steven G. Kelsen - Rydal PA, US
Carlos A. Barrero - Philadelphia PA, US
Oscar Mauricio Perez Leal - Barranquilla, CO
Assignee:
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - PHILADELPHIA
International Classification:
G01N 33/577
US Classification:
4241391, 436501, 424 946, 424 9464
Abstract:
Provided is a method for diagnosing and/or staging COPD based on detection of one or more histone proteins. In some embodiments, the histone protein is an H3.3 protein comprising a post-translational modification. In some embodiments, the histone protein is H2B, H3, H3.3 or H4. Kits for practicing the methods of diagnosis and/or staging are provided as well. Further provided is a method for treating COPD.

Ssat Mrna Translation Repression And Activation

View page
US Patent:
20140234827, Aug 21, 2014
Filed:
Aug 31, 2012
Appl. No.:
14/342063
Inventors:
Salim Merali - Bryn Mawr PA, US
Oscar Mauricio Perez Leal - Barranquilla, CO
Magid Abou-Gharbia - Exton PA, US
Wayne E. Childers - New Hope PA, US
Assignee:
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - PHILADELPHIA PA
International Classification:
A01N 1/02
C12Q 1/68
US Classification:
435 11, 435 613, 435366, 435375, 4353201, 536 231, 536 235
Abstract:
The invention provides an isolated nucleic acid having a sequence encoding a spermidine/spermine acetyltransferase (“SSAT”), wherein translation of an mRNA comprising the encoded SSAT has increased basal translation and increased stimulated translation, compared to a wild-type mRNA encoding SSAT. Methods of use for the nucleic acid are also provided. Methods and compositions are also provided for reducing ischemia-reperfusion injury in organs or tissue for transplantation.
Control profile
Salim L Merali from Philadelphia, PA, age ~62 Get Report